| Issue Date | Title | Author(s) |
| 2012-12-01 | Colicin-like bacteriocins as novel therapeutic agents for the treatment of chronic biofilm-mediated infection | Brown, CL; Smith, K; McCaughey, L; Walker, D |
| 2017-09-06 | Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis | Howlin, RP; Cathie, K; Hall-Stoodley, L; Cornelius, V; Duignan, C; Allan, RN; Fernandez, BO; Barraud, N; Bruce, KD; Jefferies, J; Kelso, M; Kjelleberg, S; Rice, SA; Rogers, GB; Pink, S; Smith, C; Sukhtankar, PS; Salib, R; Legg, J; Carroll, M; Daniels, T; Feelisch, M; Stoodley, P; Clarke, SC; Connett, G; Faust, SN; Webb, JS |
| 2017-07-01 | pIP40a, a type 1 IncC plasmid from 1969 carries the integrative element GIsul2 and a novel class II mercury resistance transposon | Harmer, CJ; Hamidian, M; Hall, RM |
| 2018-03-01 | Nitric oxide-mediated induction of dispersal in pseudomonas aeruginosa biofilms is inhibited by flavohemoglobin production and is enhanced by imidazole | Zhu, X; Oh, HS; Ng, YCB; Tang, PYP; Barraud, N; Riceb, SA |
| 2017-01-13 | Real Time, Spatial, and Temporal Mapping of the Distribution of c-di-GMP during Biofilm Development | Nair, HAS; Periasamy, S; Yang, L; Kjelleberg, S; Rice, SA |
| 2018-12-01 | Minimal attachment of Pseudomonas aeruginosa to DNA modified surfaces | Pingle, H; Wang, PY; Cavaliere, R; Whitchurch, CB; Thissen, H; Kingshott, P |
| 2016-01-01 | Discovery, characterization and in vivo activity of pyocin SD2, a protein antibiotic from Pseudomonas aeruginosa | McCaughey, LC; Josts, I; Grinter, R; White, P; Byron, O; Tucker, NP; Matthews, JM; Kleanthous, C; Whitchurch, CB; Walker, D |
| 2022-08-18 | ToxR is a c-di-GMP binding protein that modulates surface-associated behaviour in Pseudomonas aeruginosa. | Dubern, J-F; Romero, M; Mai-Prochnow, A; Messina, M; Trampari, E; Gijzel, HN-V; Chan, K-G; Carabelli, AM; Barraud, N; Lazenby, J; Chen, Y; Robertson, S; Malone, JG; Williams, P; Heeb, S; Cámara, M |
| 2022-08-18 | Elevated c-di-GMP Levels and Expression of the Type III Secretion System Promote Corneal Infection by Pseudomonas aeruginosa. | Yam, JKH; Aung, TT; Chua, SL; Cheng, Y; Kohli, GS; Zhou, J; Constancias, F; Liu, Y; Cai, Z; Salido, MMS; Drautz-Moses, DI; Rice, SA; Schuster, SC; Boo, ZZ; Wu, B; Kjelleberg, S; Tolker-Nielsen, T; Lakshminarayanan, R; Beuerman, RW; Yang, L; Givskov, M |
| 2018-02-01 | Insights into biofilm dispersal regulation from the crystal structure of the PAS-GGDEF-EAL region of RbdA from Pseudomonas aeruginosa | Liu, C; Liew, CW; Wong, YH; Tan, ST; Poh, WH; Manimekalai, MSS; Rajan, S; Xin, L; Liang, ZX; Grüber, G; Rice, SA; Lescar, J |
